Cargando…
Assessing Adherence to Adjuvant Hormone Therapy in Breast Cancer Patients in Routine Clinical Practice
BACKGROUND: Adjuvant hormone therapy (HT) in patients with hormone receptor-positive breast cancer (BC) increases overall survival (OS). A lack of adherence to adjuvant endocrine therapy is common, 31.0-73.0% of women discontinue endocrine treatment before 5 years. The aim of the study was to assess...
Autores principales: | Camejo, Natalia, Castillo, Cecilia, Tambasco, Clara, Strazzarino, Noelia, Requena, Nicolas, Peraza, Silvina, Boronat, Anna, Herrera, Guadalupe, Esperon, Patricia, Cuello, Mauricio, Krygier, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409554/ https://www.ncbi.nlm.nih.gov/pubmed/37560342 http://dx.doi.org/10.14740/wjon1647 |
Ejemplares similares
-
Survival and Time to Initiation of Adjuvant Chemotherapy Among Breast Cancer Patients in Uruguay
por: Castillo, Cecilia, et al.
Publicado: (2021) -
An improved scattering routine for collimation tracking studies at LHC
por: Tambasco, Claudia
Publicado: (2014) -
Inclusion of information technology-based assessments of health-related quality of life in routine oncology practice in Uruguay
por: Castillo, Cecilia, et al.
Publicado: (2022) -
Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer [Letter]
por: Bekele, Firomsa
Publicado: (2021) -
Population‐based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants
por: Castillo, Cecilia, et al.
Publicado: (2022)